Search This Blog

Monday, August 6, 2018

Diplomat Pharmacy cuts FY18 EPS view to (15c)-1c from 6c-17c, consensus 92c


Sees FY18 revenue $5.5B-$5.9B, consensus $5.67B. “Our EPS expectations assume approximately 74,300,000 weighted average common shares outstanding on a diluted basis and a tax rate of (5)% and 32%, for the low- and high-end of the range, respectively, for the full year 2018, each of which could differ materially. ”

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.